Epic Research

Tuesday, January 29, 2013

Epic Update : GSK

GSK has entered into an agreement to form a 50:50 joint venture (JV) with a leading Indian vaccines company, Biological E, for the early stage research and development of a six-in-one combination paediatric vaccine. This vaccine will help to protect children in India and other developing countries from polio and other infectious diseases.

Get Free MCX TipsStock TipsForex Tips & NCDEX Tips,Commodity TipsShare Tipscommodity tips free trialnifty free tipscommodity trading tipsshares tipsShare Market TipsStock Market Tipsfree stock tips on mobileStock trading tipsIntraday Tips.

No comments:

Post a Comment